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Abstract 
Using nationally representative data from 1995 and 2000, this study examined how managed 
care penetration and other organizational characteristics were related to accessibility to outpatient 
substance abuse treatment. At  an organizational level, access was measured as the percentage 
o f  clients unable to pay for  services; the percentage of  clients receiving a reduced fee; and the 
percentage of  clients with shortened treatment because o f  their inability to pay. Treatment units with 
both relatively low and relatively high managed care penetration were more likely to support access 
to care; these units provided care to higher percentages o f  clients unable to pay and were less likely 
to shorten treatment because o f  client inability to pay. Treatment units with midrange managed care 
penetration were least likely to support access to care. The complexity o f  managing in an environment 
o f  conflicting incentives may reduce the organization's ability to serve those with limited financial 
means. 
As managed care organizations promote the use of  gatekeepers, specialized utilization review, 
and outpatient over inpatient care, concerns have been raised about how managed care has altered 
the quality of  and access to behavioral treatment services. 1-3 On the one hand, advocates claim 
that managed care holds the promise of  increasing access and curbing sharply escalating costs 
by curtailing unnecessary utilization, discouraging ineffective treatment practices, and providing 
incentives for increased operating efficiency. 4 However, critics argue that behavioral  managed care 
reduces access to and effectiveness of  care both by potentially crowding out those clients who are 
unable to pay for treatment and by reducing desirable levels of  care in the name of  efficiency, t-3"5"6 
Although such concerns have been expressed most often in public policy forums, there is little 
empirical  evidence from national samples of  substance abuse treatment providers that might guide 
policy-makers in these debates. Further, the sharply partisan character of  these discussions has 
deflected attention from the possibil i ty that managed care may, under different conditions, lead to 
different outcomes with respect to access and level of  treatment. 
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The goals of this study are to evaluate how managed care affects access to outpatient substance 
abuse treatment (OSAT) and to evaluate how managed care affects the level of substance abuse 
treatment. Using a nationally representative sample of OSAT units, this research examines the re- 
lationship between managed care and 3 important measures of patient access and treatment levels. 
Treatment access is conceptualized as the willingness of a unit to remove or ease financial barriers 
to treatment and is measured using 2 dependent variables: (1) the percentage of clients treated by the 
OSAT who are unable to pay for their treatment and (2) the percentage of clients for which the OSAT 
charges reduced fees. Level of treatment is conceptualized as the extent to which a unit will continue 
to provide care, regardless of a clients' financial situation, and is measured as (3) the percentage of 
clients receiving shortened treatment because of client inability to pay. Two research questions are 
explored: 
1. Is managed care penetration in OSAT units associated with access to and level of treatment 
provided in these units? 
2. Is the relationship between managed care and access and level of treatment monotonic or, 
alternatively, does this relationship vary across levels of managed care penetration? 
Managed Care and Drug Abuse Treatment 
Outpatient substance abuse treatment units represent a central component of the drug abuse delivery 
system, accounting for nearly 70% of those in treatment. 7 Managed care firms often prefer outpatient 
treatment services because of lower costs relative to inpatient and residential settings and because 
outpatient care is often the least restrictive alternative for clients. 8,9 
In 1999, about 47% of OSAT units were involved in managed care, with, on average, 49% of their 
revenues coming from managed care arrangements. 1° OSAT units are most dependent on private 
managed care arrangements, which constitute 18% of revenues, compared with 12% from Medicaid 
managed care and 9% from other public managed care programs. 
The most common form of managed care oversight involves limiting the number of visits received 
by clients. On average, 78% of OSAT managed care clients are subject to some type of visit limits 
from the managed care firm. Managed care firms are also involved in the specification of the nature 
and types of treatment to be reimbursed. On average, managed care firms specify the content of 
treatment plans for 48% of managed care clients and require follow-up with clients after discharge 
for 23% of all managed care cases. Managed care firms disallowed claims after treatment ended 
for an average 32% of managed care clients. 11 These studies all suggest that managed care varies 
in its approach to cost and care management and that such variation may occur not only across 
organizational providers but also within providers as a function of their dependence on managed 
care.  
Most research on managed care has focused on a few large-scale managed care programs and 
their effects on clients' access to and use of treatment services. For example, one widely cited 
study examined effects of the Massachusetts statewide managed care system for Medicaid men- 
tal health and substance abuse benefits. 12 A recent review of results from studies of the effects 
of managed care on behavioral health services suggests that there is evidence of reductions in the 
use of both inpatient and outpatient treatment. Steenrod et a113(p27) conclude that " . . .  the emerg- 
ing pattern of reductions in access to alcohol and drug abuse services in commercial health plans 
and public plans for state employees and Medicaid enrollees is disturbing and a clear indica- 
tor that much more attention must be directed toward the analysis of substance abuse 
treatment." 
Several problems, however, characterize this research. First, there are few comprehensive studies 
that focus specifically on managed care activities and their effects in outpatient settings. Hence, there 
is no clear understanding of how managed care may influence treatment practices. Second, those 
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studies that focus on the organizational effects of managed care have included either a small number 
of  case studies or a single state managed care initiative. The findings to date may therefore be biased 
by the specific attributes of a few managed care programs or a single state Medicaid system. Finally 
and perhaps most important, the research to date has generally not considered how the effects of 
managed care on treatment access and level may vary as a function of the providers' dependence on 
managed care. 
Alexander and Lemak 14 examined treatment unit directors' perceptions of the costs and benefits of 
managed care. Their results indicate that directors view the impact of managed care more negatively 
to the extent that a moderate number of their clients (relative to a low or high number) are covered by 
managed care. The authors suggested that when managed care represents a minor element of the unit's 
business there is little need to change standard operating practices. As the proportion of managed care 
business increases, both administrative and clinical conflicts may result between externally imposed 
requirements and standard operating practices of the unit. Finally, as managed care becomes a 
dominant source of clients and payment, managed care protocols may be mainstreamed, resulting 
in fewer perceived conflicts with premanaged care practices. Similarly, VanHorn and colleagues 15 
reported that physicians in the general health care sector changed their clinical practice patterns at 
threshold levels of managed care. Specifically, managed care as a proportion of a clinician's caseload 
did not appreciably affect general clinical behavior until it reached a threshold point, after which 
these practices and behaviors were applied widely across a physician's client base, regardless of 
whether those clients were actually insured under managed care. 
These results suggest that the way in which managed care affects access to and levels of care for 
substance abuse treatment clients may change over the range of managed care penetration in a unit. 
In OSAT units such nonlinear effects occur because the treatment requirements and pressures for 
financial efficiency imposed by managed care may often conflict with preexisting clinical practices 
and financial incentives. Organizations will attempt to resist the imposition of requirements by 
managed care on OSAT unit operations to the extent that they can afford to engage in such resistance. 
However, they must seek a way of accommodating preexisting practices with new ones imposed under 
managed care as dependence on managed care increases. 
Perhaps nowhere are these dynamics more apparent than in the area of access to and care for 
financially disadvantaged clients. Both critics and proponents of managed care have argued that 
managed care places increased financial pressure on OSAT units by reimbursing care at lower rates 
and tying payment to more limited treatment periods) 6 These financial incentives force OSAT units 
to engage in practices that place greater emphasis on financial viability and efficiency. Those clients 
who are unable to pay because they lack insurance coverage, or cannot pay for services out of pocket, 
or cannot pay a price sufficient to cover costs, are a direct financial liability to OSAT units under this 
scenario. 
OSAT units may be likely to reduce or eliminate such financial losses through 3 mechanisms. 
The first is to reduce access to services by clients who are unable to pay. Second, for those clients 
who are uninsured or underinsured, the OSAT unit facing managed care pressures may show greater 
reluctance to reduce fees for services for these groups. Finally, OSAT units may engage in efforts to 
curtail the quantity (ie, level) of services provided to clients as a way of expending fewer resources 
per case. 
Consistent with the literature described above, this work posits that these practices may assume a 
nonmonotonic relationship with managed care penetration in the OSAT unit. At low levels of managed 
care penetration, pressures to increase efficiency are minimal, and access to services by disadvantaged 
groups may be relatively unaffected. However, at higher levels of managed care penetration, financial 
pressures on OSAT units increase, and we anticipate greater attempts to reduce access, eliminate 
financial subsidies, and shorten treatment for nonpaying clients. At very high levels of managed care 
penetration, however, conflicts between traditional treatment practices and universal access, on the 
one hand, and pressures by managed care to increase efficiency and financial viability, on the other, 
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are reduced. This is so because at very high levels, managed care requirements essentially become 
synonymous with the standard operating practices of the OSAT unit. These arguments lead to the 
following hypotheses: 
Hypothesis 1: OSAT units with either very low or very high levels of managed care penetration will 
be more likely to accept clients who are unable to pay relative to OSAT units with midrange levels 
of managed care penetration. 
Hypothesis 2: OSAT units with either very low or very high levels of managed care penetration 
will be more likely to offer clients reduced fees for services rendered relative to OSAT units with 
midrange levels of managed care penetration. 
Hypothesis 3: OSAT units with either very low or very high levels of managed care penetration will 
be less likely to shorten the duration of treatment relative to OSAT units with midrange levels of 
managed care penetration. 
Methods 
Sample and data collection 
This study uses data from 2 nationally representative samples of outpatient substance abuse treat- 
ment (OSAT) units surveyed in 1995 and 1999/2000 as part of the National Drug Abuse Treatment 
System Survey (NDATSS). The NDATSS is a longitudinal program of research into the organi- 
zational structure, operating characteristics, and treatment modalities of such units in the United 
States. 11 In the NDATSS, an OSAT unit is formally defined as a physical facility with resources 
dedicated primarily (more than 50%) to treating individuals with substance abuse problems (includ- 
ing alcohol and other drugs) on a nonresidential basis. The sample was specifically designed to 
represent the wide variety of organizations that comprise the nation's complex outpatient treatment 
system. 
Details of the study design and methods used in the NDATSS have been described elsewhere) 7"18 
Briefly, the NDATSS uses a mixed panel design, which combines elements from panel and cross- 
sectional design formats. Data are collected from the same national sample of outpatient drug abuse 
treatment units, which have been sampled and screened as part of prior waves of the study. These 
panel units are combined with a new group of randomly selected OSAT units to insure that the 
sample remains nationally representative. The new units are selected for participation from a sampling 
frame of the most complete list of the nation's outpatient substance abuse treatment units, compiled 
by Institute for Social Research at the University of Michigan. In the 1995 wave, the sample was 
stratified by control status, treatment modality (methadone or non-methadone), and organizational 
affiliation. The 1999/2000 wave sample was stratified by treatment modality (methadone or non- 
methadone). Except as noted, variables from the NDATSS for both the 1995 and the 1999/2000 
waves of data were combined as a panel and cross-sectional data file. 
After screening and nonresponse, 618 organizations completed interviews in the 1995 wave, 
and 745 organizations completed interviews in the 1999/2000 wave, with response rates of 88% 
and 89%, respectively. Several steps were followed to produce reliable and valid telephone survey 
data, including two pretests, elaborate interviewer training, extensive checks for consis- 
tency within and between sections of the survey instrument, and, when necessary, recontacts with 
respondents) 9 
The director and clinical supervisor of each participating OSAT unit were asked to complete 
telephone interviews. Directors provided information concerning the unit's control status, environ- 
ment, finances, parent organizations, and managed care arrangements. Clinical supervisors provided 
information about staff, clients, treatment practices, and services provided. After the data were 
collected, extensive reliability checks were performed within each survey. Results were also 
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compared between surveys further to confirm validity. These checks revealed very high levels of 
consistency in the NDATSS data) 6'2°,21 
Measures 
Table 1 displays descriptions and weighted descriptive statistics for the dependent and independent 
variables, which are described below. 
Dependent var iables  
This research considers 3 mechanisms that units may employ as means to reduce or eliminate 
financial losses and increase financial efficiency. These mechanisms potentially improve financial 
viability of the treatment unit by controlling initial or continued access to care. 
Table 1 




Access to treatment 
% Clients unable to pay for treatment 24.41 
% Clients paying reduced fee for treatment 41.41 
Level of treatmen 
% Clients receiving shortened treatment because of client inability to pay 1.87 
Independent variables 
Managed care penetration 
% Clients 17.34 
Treatment unit affiliation 
Hospital affiliation 0.16 
Mental health center affiliation 0.21 
Freestanding unit 0.29 
Other affiliation (referent category) 0.34 
Treatment unit ownership 
Public 0.28 
Private not-for-profit 0.53 
Private for-profit (referent category) 0.19 
Available treatment modality 
Methadone (1 = unit provides methadone treatment) 0.15 
Client characteristics 
% Clients African American 22.05 
% Clients unemployed 39.71 
% Clients with dual diagnoses 31.75 
% Clients with prior treatment 62.05 
Year of data 


















Note: Descriptive statistics are weighted to be nationally representative. 
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Access to substance abuse treatment. Two dependent variables describe the accessibility of care 
within a treatment unit for uninsured or underinsured clients. Percentage of  clients unable to pay 
for treatment reveals the willingness of a unit to care for the indigent substance abuse treatment 
population. Some units receive funding to supplement the care for these uninsured clients. However, 
financial pressures of managed care may tighten total available financial resources, forcing limitations 
in treatment access. 
Percentage of  clients paying a reduced fee reflects the willingness of a unit to provide services to 
clients who may be unable to pay full price because they are uninsured or underinsured. Similar to 
measuring access for clients unable to pay, this measure may reveal how financial capabilities and 
the mission of the treatment unit respond to managed care participation. 
Level of  substance abuse treatment. The third dependent variable describes the unit's commitment 
to a prescribed level of treatment, regardless of their clients' financial standing. Level of treatment 
is operationalized by measuring the percentage of clients receiving shortened treatment because of  
client inability to pay. This dependent variable reveals the percentage of clients whose treatment 
ended prematurely because of financial constraints. This describes an additional method a unit may 
employ to manage its financial condition in a managed care environment. The ability and commitment 
of a unit to continue providing "full service" care may be limited if managed care requirements have 
already stretched resources, a 
Independent variables 
In this study, managed care is defined as any contractual or noncontractual arrangement that 
imposes treatment guidelines or restrictions that must be followed in order for the OSAT units to 
receive payment for services provided. Arrangements may be with public or private managed care 
programs. Public managed care programs comprise arrangements with Medicaid or other government 
programs. Private managed care programs include arrangements with health maintenance organiza- 
tions (HMOs), preferred provider organizations (PPOs), exclusive provider organizations (EPOs), 
or Employee Assisted Programs (EAPs). 1° As described earlier, treatment guidelines and require- 
ments may include preauthorization, utilization review, treatment planning, and documentation of 
outcomes. Managed care penetration for each OSAT unit is measured as the percentage of OSAT 
clients covered under either a contractual or noncontractual managed care arrangement. 
To allow for the possibility that characteristics of the organization might influence access to and 
level of treatment, we include unit affiliation, ownership status, and treatment modality. Treatment 
units may be independent or owned or managed by organizations such as hospitals or mental health 
centers. Such affiliation is measured by 3 dummy variables: hospital, mental health center, or free- 
standing, with "other" affiliation as the referent category. 
Ownership status of the treatment unit is identified as either public, private not-for-profit, or private 
for-profit. Two dummy variables represent ownership in the model, with private for-profit status as 
the referent category. Methadone modality is measured by a single dummy variable indicating the 
unit's participation in this treatment protocol. 
Previous research has shown that certain client characteristics are associated with more complex 
treatment and service needs. Resources may be further stretched by these complex cases, thereby 
potentially affecting access to and the level of treatment. African American clients with substance 
abuse disorders often exhibit more complex treatment needs as a result of the social, economic, 
and health status disadvantages they may experience. 22 Other client characteristics shown to be 
associated with increased case severity include clients who are unemployed, 23-25 clients with mental 
health problems in addition to their addiction problem---or dual diagnoses, 26 and clients with some 
prior substance abuse treatment. 27'28 
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Analysis strategy 
The unit of analysis was the treatment unit. The data were analyzed in 3 stages. First, descriptive 
statistics were calculated to examine variation and distribution in the predictors and dependent 
variables. Univariate statistics were weighted to account for the stratified sampling design. 17 Next, 
bivariate correlations were examined to test for multicollinearity; these results did not produce any 
analytic constraints (Table 2). 
The dependent variable measures were represented by proportional variables; therefore, logistic 
regression models were fit to study the associations between predictor and access variables. Exam- 
ination of the data suggested that due to the large number of zero values, the dependent variables 
were overdispersed, ie, variances of the dependent variables were larger than the binomial variables 
assumed for proportional variables under conventional logistic regression models. Such overdisper- 
sion results in invalid statistical inference under standard logistic regression. Specifically, standard 
errors and associated P values for the regression coefficients obtained under standard logistic re- 
gression are artificially small. This results in potentially inappropriate significance for the covariate 
effects. 
In addition to overdispersion of the dependent variables, the research design had a longitudinal 
component, where most units have observations from 2 data waves (1995 and 1999/2000). Gen- 
eralized estimating equations (GEE), a multivariate analog of logistic regression, accounted for 
correlation among repeated measures on the same unit over time and corrected for overdispersion 
of the dependent variables. An important feature of GEE is that parameter estimates have the same 
interpretation as parameters estimated using generalized linear models (GLM) for cross-sectional 
data. GEE accounts for overdispersion and within-unit correlation by correcting the standard errors of 
the regression coefficient estimates from standard logistic regression, using the sandwich method. 29 
An advantage of the sandwich method is that it does not require the correct specification of the 
within-unit correlation matrix. 
Two models were fit for each dependent variable: model 1 contains all covariates representing 
potential alternative explanations of the relationship between managed care penetration and access to 
or level of treatment in OSAT units plus the linear specification of managed care penetration. Model 
2 is identical to model 1 except that a quadratic (squared) term was added to represent potential 
nonlinear associations between managed care and the dependent variable. To determine whether 
dependent variables vary over time, a variable representing the year in which the data were collected 
was included in all models. Interaction terms representing the joint effects of year and each of the 
covariates were tested to determine whether covariant effects vary by year. These interaction terms 
proved to be insignificant and therefore were not reported. 
Results 
Descriptive data presented in Table 1 reveal that an average of 24% of OSAT unit clients were 
unable to pay for treatment; another 41% paid a reduced fee for treatment. Once treatment was 
initiated, it was less likely that it would be interrupted because of financial constraints. As shown 
in Table 1, only 2% of the clients received shortened treatment because of client inability to pay 
for continued care. Half of the treatment units participated in some form of managed care. For all 
units in this sample, an average of 17% of clients were covered under a managed care arrangement 
(managed care penetration). When analyzing only those units participating in manage care, 34% of 
clients treated in these units were covered under some type of managed care arrangements. 
Review of the organizational characteristics indicates that 16% were affiliated with hospitals, 
21% were affiliated with mental health care centers, 29% of the units were freestanding, and 
the remaining 34% claimed some other type of unit affiliation. Units were predominately pri- 
vate not-for-profit organizations (53%) with the remaining units split between public (28%)and 
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private for-profit (19%) ownership status. Methadone treatment was available in 15% of the 
units. 
Client characteristics indicate that 22% of the clients were African American, 40% were unem- 
ployed, 32% were dually diagnosed with mental health and substance abuse conditions, and 62% 
had prior treatment either at the current treatment unit or elsewhere. 
Multivariate results 
Table 3 presents the multivariate GEE results for the 3 dependent variables: percentage of clients 
unable to pay; percentage of clients paying a reduced fee; and percentage of clients receiving 
shortened treatment. For each of the 3 dependent variables, 2 regression models are provided. 
In model 2, a quadratic term was added to model 1 to test the nonmonotonic effect of managed 
c a r e .  
Access to treatment 
Percentage of  clients unable to pay 
Model 1 indicates that managed care penetration exercised a significant and negative effect on 
the percentage of clients unable to pay for care in OSAT units. As the percentage of managed care 
activity in OSAT increases, units are less likely to treat clients who are unable to pay for their care. 
In model 2 both the linear term representing managed care penetration and the quadratic (squared) 
term are significant. These results suggest that the relationship between managed care penetration 
and percentage of clients unable to pay assumes a U-shaped curve (see Figure 1). OSAT units with 
low managed care penetration and OSAT units with high managed care penetration are more likely 
to treat larger numbers of clients unable to pay relative to units with managed care penetration at 
mid levels of the range. These results are consistent with hypothesis 1. 
Other findings indicate that public and private not-for-profit OSAT units are more likely than their 
private for-profit counterparts to treat larger percentage of clients who are unable to pay. Results also 
suggest that hospital-based units and freestanding units are more likely than other types of OSAT 
units to treat large numbers of clients who are unable to pay. Methadone units also are less likely 
to treat nonpaying clients. None of the variables representing client mix proved to be a significant 
predictor of percentage of clients unable to pay. 
Percentage of  clients paying a reduced fee  for  substance abuse treatment services 
Results reported in model 1 suggest that managed care is not a significant predictor of the per- 
centage of clients paying reduced fee for substance abuse treatment services. For this dependent 
variable, adding a quadratic term did not improve the explanatory power of managed care on per- 
centage of clients paying reduced fees. Compared to their for-profit counterparts, public and private, 
not-for-profit OSAT units are more likely to offer clients reduced fees for services rendered. While 
hospital-based units are less likely to provide such reduced fees, OSAT units affiliated with mental 
health centers are significantly more likely to provide such a reduced fee program to their clients. 
Finally, OSAT units with a larger percentage of black clients are less likely to provide reduced fees 
than comparable units with a smaller percentage of black clients. Collectively, these results suggest 
that although organizational affiliation, ownership, and client mix exercise significant effects on the 
percentage of clients receiving reduced fees for services, managed care does not appear to impact 
this approach to service delivery. 
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Table 3 
GEE regression results for (model 1) base model and (model 2) nonmonotonic model (n = 1092) 
Access to treatment Level of treatment 
Unable to pay Reduced fee Shortened treatment 
Model I Modal 2 Model 1 Model 2 Model I Model 2 
% Clients with managed care 
Estimate -0 .0129§ -0 .0429§ 0.0021 0.0043 0.0134§ 0.0411 ~: 
SE 0.0031 0.0093 0.0030 0.0105 0.0036 0.0154 
% Clients with managed 
care squared 
Estimate . . .  0.0004§ . . .  0.0001 . . . .  0.0003* 
SE . • • 0.0001 • • • 0.0001 • • • 0.0002 
Hospital affiliation 
Estimate - 0 . 8 7 0 6  :~ -0 .7848  :~ -0 .6563  t - 0 . 6625  f 0.0879 0.0470 
SE 0.2961 0.2925 0.3016 0.2977 0.3871 0.3877 
Mental health center affiliation 
Estimate - 0 . 2 0 9 6  - 0 . 2 3 5 4  0.5698 :l: 0.5725 :~ -0 .4215  -0 .3815  
SE 0.2172 0.2178 0.2187 0.2189 0.5223 0.5128 
Freestanding unit 
Estimate - 0 .3117  -0 .3662* -0 .0187  - 0 . 0 1 3 6  -0 .2911  - 0 . 2 5 0 2  
SE 0.2218 0.2208 0.1968 0.1969 0.3705 0.3717 
Public 
Estimate 1.4683§ 1.4264§ 1.9180§ 1.9239§ -1 .6336  ¢ - 1 . 4 7 9 9  :~ 
SE 0.3649 0.3704 0.3362 0.3339 0.5409 0.5377 
Private not-for-profit 
Estimate 1.4596§ 1.4292§ 1.7489§ 1.7529§ - 1.3067§ - 1.2469§ 
SE 0.3305 0.3379 0.2976 0.2951 0.3728 0.3817 
Methadone 
Estimate - 0 .4679  f - 0 . 5017  t - 0 . 1 3 6 9  -0 .1341  1.4797§ 1.5097§ 
SE 0.2458 0.2473 0.2036 0.203 l 0.3093 0.3104 
% Clients African American 
Estimate 0.0043 0.0038 -0 .0108  ~: - 0 . 0 1 0 8  :~ -0 .0135  t - 0 . 0 1 3 0  t 
SE 0.0034 0.0034 0.0035 0.0035 0.0061 0.0062 
% Clients unemployed 
Estimate 0.0033 0.0030 -0 .0027  - 0 . 0 0 2 7  -0 .0024  - 0 . 0 0 3 7  
SE 0.0038 0.0039 0.0044 0.0044 0.0067 0.0071 
% Clients with dual diagnoses 
Estimate 0.0037 0.0034 0.0001 0.0001 0.0106t 0.0102t 
SE 0.0037 0.0037 0.0033 0.0033 0.0051 0.0052 
% Clients with prior treatment 
Estimate -0 .0035  - 0 , 0 0 3 6  - 0 . 0 0 0 2  - 0 . 0 0 0 2  0.0021 0.0033 
SE 0.0031 0.0031 0.0031 0.0030 0.0056 0.0056 
Year 
Estimate 0.2730* 0.2827* - 0 . 2 0 7 9  - 0 . 2 0 7 6  - 0 . 2 9 2 4  -0 .2223  
SE 0.1480 0.1489 0.1488 0.1488 0,2688 0,2650 
Intercept 
Estimate -2 .2974§ -2 .1244§ -1 .3183§ -1 .3353§  -3 .7438§ -4 .0316§ 
SE 0.4292 0.4326 0.3412 0.3436 0.5448 0.5115 
Note: Pooled data from wave 4 (1995) and wave 5 (1999/2000). The logged odds parameter estimates are from multivariable logistic 
GEE models with robust standard errors. 
*P < .10. 
t p  < .05. 
:~P < .01. 
§P < .001. 
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Figure 1 
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% of  Clients with M a n a g e d  C a r e  
Level of  treatment 
Percentage o f  clients receiving shortened treatment because o f  client inability to pay 
Model 1 indicates that managed care penetration exhibits a significant and positive association 
with the percentage of clients receiving shortened treatment because of c~_ient inability to pay. When 
the quadratic expression of managed care penetration is added in model 2, results indicate that 
the association between the managed care and proportion of clients receiving shortened treatment 
assumes a curvilinear form in which increasing managed care penetration initially leads to short- 
ened treatment sessions for OSAT clients. However, this relationship plateaus and even declines 
slightly at 60% managed care penetration (see Figure 2). This pattern of results is generally con- 
sistent with predictions made with hypothesis 3. Not surprisingly, public and private not-for-profit 
OSAT units are less likely than their for-profit counterparts to shorten treatment periods for their 
clients. Similarly, methadone units are much more likely to shorten treatment periods for their clients 
than are non-methadone units. Among the client mix characteristics, units with a higher percent- 
age of black clients are less likely to reduce treatment periods for their clients, and units with 
a high percentage of dual diagnosis clients are more likely to reduce treatment periods for their 
clients. 
To further validate the nonlinear effects noted above, categorical variables were substituted for 
representative range segments of the distribution of managed care penetration. Results (not shown) 
support the general conclusions previously cited when examining the combination of main effects 
term and quadratic term of managed care penetration. 
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Figure 2 
Relationship between managed care penetration and percentage of clients receiving shortened 
treatment because of their inability to pay 
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Discussion 
This study has examined how managed care affects the treatment practices and policies of OSAT 
units. Results indicate that managed care affects both access to and level of treatment provided in such 
units. However, such effects are shown to vary over the range of values of managed care penetration 
in OSAT units. One interpretation is that the operational and strategic meaning of reducing access 
to nonpaying clients, or shortening treatment, may differ substantively depending on the level of 
dependence of the OSAT unit on managed care. This suggests that managed care should be viewed 
as much as an important contextual variable providing meaning to organizational strategies and 
practices as it is a direct determinant of such practices. 
The findings indicate that units involved with managed care will employ different strategies to 
meet financial requirements and that they will use such strategies differently at different levels 
of managed care penetration. For example, OSAT units characterized by both very low and very 
high levels of managed care penetration permitted greater access to clients unable to pay compared 
to OSAT units involved with mid-level managed care penetration. At low levels of managed care 
penetration, units are less constrained by efficiency requirements of managed care firms and therefore 
may be more likely to admit greater numbers of patients who are unable to pay for their care. At 
high levels of managed care penetration, efficiencies may have been achieved, thereby affording 
OSAT units the ability to accept greater numbers of patients who are unable to pay. Alternatively, 
units with high managed care penetration may have the added advantage of a stable revenue source 
and therefore may be in a better position to provide services to those unable to pay. However, 
at middle range levels of managed care penetration, pressures to achieve efficiencies imposed by 
managed care firms likely conflict with traditional practices of care to the uninsured. When external 
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demands are significant but not dominant, pressures to achieve operating efficiencies may be at their 
greatest, resulting in lower levels of access to nonpaying clients. These results are consistent with 
previous studies of the effects of managed care on treatment outcomes for drug abuse treatment 
clients. 14 
The pattern of relationships between managed care penetration and measures of treatment level 
is similar to that reported for number of clients unable to pay. Consistent with the hypothesis, 
as managed care penetration increases, the tendency to provide shortened treatment sessions also 
increases. However, this effect plateaus and starts to decline when managed care penetration reaches 
60%. Units with middle ranges of managed care penetration are most likely to reduce treatment 
duration for their clients, just as these units are the least likely to serve large numbers of clients who 
are unable to pay. 
Implications for Behavioral Health Services 
For policy-makers, the findings indicate that OSAT units respond differently to managed care as a 
function of (a) their dependence on managed care (managed care penetration); (b) the strategies and 
policies by which these organizations attempt to increase efficiency; and (c) the different substantive 
meanings assumed by access and treatment approaches at different levels of managed care. This is a 
much more nuanced picture of managed care than has been presented in most previous studies. It sug- 
gests that there are clearly contradictory pressures and incentives at work in treatment organizations. 
On the one hand, substance abuse treatment professionals are dedicated to providing care that would 
result in the greatest good for their clients, including freedom from substance abuse, maintenance 
of treatment regimens, and sustained contact with treatment providers and provider organizations. 
On the other, managed care pressures frequently operate with requirements to reduce costs of care 
and provide strong incentives to promote operating efficiencies in OSAT delivery. Because such 
requirements are often at odds with the objectives of treatment professionals, organizations respond 
in somewhat contradictory ways as a means of balancing them. 
It is also important for policy-makers to note that there are clear thresholds at which treatment 
practices and access to care change in OSAT units exposed to managed care. The likelihood of 
shortening treatment duration, for example, does not increase linearly with managed care penetration, 
but levels off at some point. Similarly, access to care for those unable to pay drops with increasing 
managed care penetration up to a point but then increases. These findings should promote careful 
consideration by policy-makers of how much managed care is too much, or alternatively, how much 
managed care is required to see a difference in operating efficiencies within OSAT units. 
It is important to note that this study examined changes in access to and level of treatment for all 
clients in OSAT units, not simply clients covered in managed care. This is an important distinction 
because it speaks to the adoption and diffusion of practices that may affect a larger population of 
clients than those specifically targeted by managed care firms. These findings strongly suggest that 
it is difficult for OSAT units to apply different policies and practices to managed care clients and 
non-managed care clients. This is particularly true as the levels of managed care penetration rise in 
OSAT units. As the level of dependence on managed care revenue increases, requirements imposed 
by managed care and the norms of efficiency are adopted as the standard practices of the organization, 
not simply as limited responses to gain reimbursement. These findings are consistent with those of 
Van Horn et a115 and others in the general health care sector. 
No effects of managed care were found on the tendency of OSAT units to reduce fees for substance 
abuse clients. Although this practice is common in the sample (40% of all units), high and low 
managed care penetration OSAT units appear to be equally likely to engage in this practice. However, 
the strategic and financial importance of this practice may differ between high and low penetration 
units. For units characterized by low managed care penetration, the reduction of fees may simply be 
an extension of access for clients who are unable to pay. For units characterized by high managed care 
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penetration, however, this strategy is a likely alternative to permitting access to those who are unable 
to pay. Such an approach may enable the unit to recover some revenue in the face of efficiency 
pressures without suffering the financial risk associated with treating clients who are unable to 
pay. Based on the results described above, this practice may be more prevalent in organizations 
characterized by midrange levels of managed care. 
Of course, the overarching policy question is the extent to which constraints on treatment access 
and delivery imposed by managed care affect the outcomes of treatment. For example, if standards 
of care are tightly constrained by managed care organizations with the aim of increasing efficiency, 
are client treatment needs being met and is the effectiveness of care diminished? 
Conclusion and Limitations 
These findings should be interpreted with caution. For example, units that limit access to services, 
or which deliberately scale back on treatment, may be more attractive to managed care firms. In other 
words, these providers may not react to the pressures of managed care but select into managed care 
arrangements because their practices are attractive to managed care firms. Although such endogeneity 
concerns are somewhat obviated by the nonlinear effects of managed care, a longitudinal design or 
an instrumental variables approach to assessing this possibility is clearly called for in future studies. 
Second, the study may suffer from some omitted variable bias. The approach used to address this 
issue was to include as covariates organizational and client characteristics that represent potential 
alternative explanations to the relationship between managed care and access to and level of treatment. 
For example, ownership and affiliation exercise consistent effects on the dependent variables. 
Although the measure of managed care used in this study was purposely comprehensive, there may 
be benefit to deconstructing managed care into specific requirements and organizational types. For 
example, previous research has been criticized on the grounds that managed care represents a broad 
family of financial incentives and treatment requirements that can vary widely in their effects on 
providers. Lack of comparability across studies has resulted from inattention to the specific elements 
of managed care arrangements with which providers must contend and the potential for multiple 
or even conflicting requirements from different managed care organizations. Accordingly, other 
measures of managed care should be examined in future studies. These might include whether or not 
there are stringent visit limits, whether or not OSAT units are specifically rewarded for improving 
efficiency, or the extent to which requirements are imposed on the actual delivery of services to 
OSAT clients. Further, future studies might examine whether such requirements vary systematically 
as a function of MCO type (eg, HMOs, behavioral carve outs, PPOs). 
In a related vein, future work should begin to examine the mechanisms by which managed care 
affects access and level of treatment by exploring its effects on individual provider behavior. We 
currently know little about how those who are charged with delivering care, individual treatment 
staff, change their behaviors as a function of the introduction of managed care arrangements in their 
organizations. To the extent that these staff represent the core production technology of substance 
abuse treatment organizations, this gap is a serious shortcoming in the ability to design both managed 
care strategies and organizational structures consistent with desired standards of care for substance 
abuse clients. Although this study has attempted to open the "black box" of the relationship between 
managed care and important client treatment practices, there is much more that remains to be done. 
Note 
Uncompensated care was evaluated as a financial indicator of accessibility. Typically, uncom- 
pensated care is composed of bad debt and charity care. However, extensive testing revealed that 
participating treatment units did not measure the components of uncompensated care with consis- 
tency or reliability. Therefore, use of this variable would not have led to valid conclusions. 
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